SCHEMBL13601885

SCHEMBL13601885

COc1cc(-c2nc(-c3ccc(CO)c(CO)c3)no2)c(F)cc1-c1cccc(F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.52
S1PR1 P21453 7/20 0.49
HSD17B10 Q99714 6/20 0.47
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
NPC1 O15118 9/20 0.43
RAB9A P51151 8/20 0.43
SMN1; SMN2 Q16637 8/20 0.43
TP53 P04637 6/20 0.43
MAPT P10636 4/20 0.43
HPGD P15428 2/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
TSHR P16473 4/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601881 0.92 ALDH1A1 (0.56) CA4S1PR1HSD17B10KDM4EALDH1A1
SCHEMBL13601858 0.87 S1PR1 (0.44) CA4S1PR1HSD17B10KDM4EALDH1A1
SCHEMBL13601840 0.79 S1PR1 (0.52) CA4S1PR1HSD17B10KDM4ENPC1
SCHEMBL13601869 0.76 NPC1 (0.46) S1PR1HSD17B10KDM4EALDH1A1MEN1
SCHEMBL13601849 0.76 RAB9A (0.49) CA4S1PR1HSD17B10KDM4EALDH1A1
SCHEMBL13601861 0.75 NPC1 (0.52) S1PR1HSD17B10KDM4EALDH1A1MEN1
SCHEMBL13601890 0.74 S1PR1 (0.44) S1PR1MEN1KMT2ANPC1RAB9A
SCHEMBL13608832 0.74 CA4 (0.46) CA4S1PR1HSD17B10KDM4EALDH1A1
SCHEMBL13601917 0.74 CA4 (0.46) CA4S1PR1HSD17B10KDM4EALDH1A1
SCHEMBL13601875 0.72 NPC1 (0.42) S1PR1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298894-A1 AMINO ACID COMPOUNDS ASAHI KASEI PHARMA CORPORATION (JP) 2009-12-03 US disclosed
US-20090298894-A1 AMINO ACID COMPOUNDS ASAHI KASEI PHARMA CORPORATION (JP) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298894-A1 AMINO ACID COMPOUNDS S1PR1, S1PR2, S1PR5 CA4 4671/4885S1PR1 1/4885HSD17B10 4113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.